KIDNEY TRANSPLANT REJECTION
Clinical trials for KIDNEY TRANSPLANT REJECTION explained in plain language.
Never miss a new study
Get alerted when new KIDNEY TRANSPLANT REJECTION trials appear
Sign up with your email to follow new studies for KIDNEY TRANSPLANT REJECTION, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Extended trial tests new transplant drug against standard treatment
Disease control ENROLLING_BY_INVITATIONThis study follows kidney transplant patients for up to four years to compare the long-term safety and effectiveness of an experimental drug called tegoprubart against the standard medication tacrolimus. The goal is to see which treatment better prevents organ rejection while cau…
Matched conditions: KIDNEY TRANSPLANT REJECTION
Phase: PHASE2 • Sponsor: Eledon Pharmaceuticals • Aim: Disease control
Last updated Apr 01, 2026 14:43 UTC
-
Scientists track patients for 15 years after groundbreaking transplant cell therapy
Disease control OngoingThis study is tracking the long-term safety of an experimental cell therapy given to kidney transplant patients. The therapy, called CAR-Treg, is designed to help the body accept the new kidney and reduce rejection. Researchers will follow 11 patients for up to 15 years to monito…
Matched conditions: KIDNEY TRANSPLANT REJECTION
Sponsor: Sangamo Therapeutics • Aim: Disease control
Last updated Apr 01, 2026 14:41 UTC
-
Simple blood test could predict kidney transplant failure
Diagnosis OngoingThis study aims to validate new blood tests that analyze gene activity to predict the risk of a patient's body rejecting a transplanted kidney. Researchers will follow 550 adult kidney transplant recipients for up to two years, collecting blood samples during their regular check-…
Matched conditions: KIDNEY TRANSPLANT REJECTION
Sponsor: Verici Dx • Aim: Diagnosis
Last updated Mar 31, 2026 12:11 UTC